NOP receptor mediates anti-analgesia induced by agonist–antagonist opioids

Clinical studies have shown that agonist-antagonist opioid analgesics that produce their analgesic effect via action on the kappa-opioid receptor, produce a delayed-onset anti-analgesia in men but not women, an effect blocked by co-administration of a low dose of naloxone. We now report the same time-dependent anti-analgesia and its underlying mechanism in an animal model. Using the Randall-Selitto paw-withdrawal assay in male rats, we found that nalbuphine, pentazocine, and butorphanol each produced analgesia during the first hour followed by anti-analgesia starting at ~90 minutes after administration in males but not females, closely mimicking its clinical effects. As observed in humans, co-administration of nalbuphine with naloxone in a dose ratio of 12.5:1 blocked anti-analgesia but not analgesia. Administration of the highly selective kappa-opioid receptor agonist U69,593 produced analgesia without subsequent anti-analgesia, and confirmed by the failure of the selective kappa antagonist nor-binaltorphimine to block nalbuphine-induced anti-analgesia, indicating that anti-analgesia is not mediated by kappa-opioid receptors. We therefore tested the role of other receptors in nalbuphine anti-analgesia. Nociceptin/orphanin FQ (NOP) and sigma-1 and sigma-2 receptors were chosen on the basis of their known anti-analgesic effects and receptor binding studies. The selective NOP receptor antagonists, JTC801, and J113397, but not the sigma receptor antagonist, BD 1047, antagonized nalbuphine anti-analgesia. Furthermore, the NOP receptor agonist NNC 63-0532 produced anti-analgesia with the same delay in onset observed with the three agonist-antagonists, but without producing preceding analgesia and this anti-analgesia was also blocked by naloxone. These results strongly support the suggestion that clinically used agonist-antagonists act at the NOP receptor to produce anti-analgesia

Apatite : a new redox proxy for silicic magmas?

The oxidation states of magmas provide valuable information about the release and speciation of volatile elements during volcanic eruptions, metallogenesis, source rock compositions, open system magmatic processes, tectonic settings and potentially titanium (Ti) activity in chemical systems used for Ti-dependent geothermometers and geobarometers. In this paper we explore the use of Mn in apatite as an oxybarometer in intermediate and silicic igneous rocks. Increased Mn concentrations in apatite in granitic rocks from the zoned Criffell granitic pluton (southern Scotland) correlate with decreasing Fe2O3 (Fe3+) and Mn in the whole-rock and likely reflect increased Mn2+/Mn3+ and greater compatibility of Mn2+ relative to Mn3+ in apatite under reduced conditions. Fe3+/Fe2+ ratios in biotites have previously been used to calculate oxygen fugacities (fO2) in the outer zone granodiorites and inner zone granites where redox conditions have been shown to change from close to the magnetite-hematite buffer to close to the nickel-nickel oxide buffer respectively ( Stephens et al., 1985). This trend is apparent in apatite Mn concentrations from a range of intermediate to silicic volcanic rocks that exhibit varying redox states and are shown to vary linearly and negatively with log fO2, such that logfO2=-0.0022(±0.0003)Mn(ppm)-9.75(±0.46)logfO2=-0.0022(±0.0003)Mn(ppm)-9.75(±0.46) Variations in the Mn concentration of apatites appear to be largely independent of differences in the Mn concentration of the melt. Apatite Mn concentrations may therefore provide an independent oxybarometer that is amenable to experimental calibration, with major relevance to studies on detrital mineral suites, particularly those containing a record of early Earth redox conditions, and on the climatic impact of historic volcanic eruptions